Abstract
6/2008
vol. 7
Thromboembolic safety of transdermal hormone therapy
Przegląd Menopauzalny 2008; 6: 285-290
Online publish date: 2009/01/05
This article is a review of up-to-date reports – the newest references and own studies – on the influence of transdermal hormone therapy (HT) on thromboembolic risk in menopausal women. The available data testify clearly to the high thromboembolic safety of HT, even when this therapy is administered in women with thromboembolic risk factors.
Keywords
menopause, transdermal hormone therapy, thromboembolic complications
Coverage in
Indexed in
Integrated with
Editorial Policies
